SynthesisFrontiers in psychiatry2026
The anxiolytic effect of dexmedetomidine in adult perioperative patients: a systematic review with meta-analysis of randomized controlled trials.
Synthesis in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Perioperative anxiety in adults is common and impairs postoperative recovery. The use of dexmedetomidine during perioperative procedures is increasing, but evidence on its effects on anxiety-related outcomes remains to be systematically synthesized. Methods: This systematic review was based on searches of PubMed, Embase, Web of Science, MEDLINE, and the Cochrane Library from database inception through May 4, 2026. Eligible studies were randomized controlled trials evaluating perioperative dexmedetomidine in adults and reporting quantitative anxiety outcomes. Results: Twelve RCTs involving 1,373 participants were included. Overall anxiety scores were lower with dexmedetomidine than with control (SMD = -0.73; 95% CI [-1.37, -0.10]; P = 0.028; I² = 94.2%; 95% prediction interval [-2.97, 1.50]). Within 24 h after surgery, the pooled estimate likewise favored dexmedetomidine (6 RCTs; SMD = -0.83; 95% CI [-1.58, -0.07]; P = 0.038; I² = 92.9%; 95% prediction interval [-2.76, 1.11]). The estimates for intraoperative anxiety, anxiety at 24-72 h postoperatively, and anxiety beyond 72 h were SMDs = 0.08 (95% CI [-2.31, 2.46]), -0.11 (95% CI [-0.41, 0.20]), and -0.31 (95% CI [-1.02, 0.39]), respectively. Postoperative sleep quality favored dexmedetomidine (4 RCTs; SMD = -0.64; 95% CI [-0.81, -0.48]; I² = 0%), whereas no clear between-group differences were observed for depression or pain. Conclusion: Perioperative dexmedetomidine was associated with reduced anxiety in adult surgical patients. Although the evidence for this association was clearer within 24 h after surgery, the limited data across time windows do not establish that the anxiolytic effect is confined to this period. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/, identifier CRD420251129414.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.